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ToolOver thepast ten years, the Public Population Project inGenomics and Society (“P3G”) has grown as a consortium.
It has expanded its range of services and resources to adapt to the ever-evolving needs of the research commu-
nity. From its outset –when P3G ﬁrst tackled the building of biobanks as resources aswell as data cataloguing and
harmonization for data integration – to its newmission and vision, it has continually developed the tools for the
conceptualization and design of population biobanks from their inception to their use to their closure. In so doing,
P3G has become key in fostering research infrastructures to facilitate transition to the clinic. The consortium has
become a crucial stakeholder in the international scientiﬁc, ethical, legal, and social research communities.
© 2014 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).Charter of Principles (adopted by P3G Board of Directors: March 23, 2007)
P3G aspires to the highest standards of ethical comportment and research
integrity. The fundamental principles that underpin its activities are:
- Promotion of the common good: P3G will optimise the beneﬁts of collaborative
research for the beneﬁt of all.
- Responsibility: Protection of the interests of all affected stakeholders including
families, groups, populations, researchers and research sponsors is the highest
priority. Every effort will be made to respond to the concerns of stakeholders in
a timely and appropriate manner.1. Introduction
The Public Population Project in Genomics and Society (P3G),
established in 2004, is a non-proﬁt international consortium focusing
on genomics and biobanking. Originally, P3G served four different but
complementary population genomics research projects: CARTaGENE
(Quebec); GenomEUtwin (FP5 (EC) project involving 8 countries);
Estonia's genome project (Estonia); and the U.K. Biobank (U.K.).
Dedicated to the development and management of multi-disciplinary
research infrastructures, it sought to facilitate translational research
via tools for prospective harmonization.
P3G quickly established itself as a key resource for biobanking
(in particular, for large cohort biobanking), and for the genomics re-
search community at large. The importance of P3G was illustrated in a
major paper in the European Journal of Human Genetics, in which the
consortium and its early achievements were introduced and discussed
(Knoppers et al., 2008). For instance, at the time of its inception, one of
the major issues with which genomic researchers had to contend was
the disparities in the type and quantity of data available (Collins et al.,
2003). This was compounded by the fact that both policy compatibility
between studies and the ability to compare and use data (e.g.
socioeconomic status, behaviours, diet, lifestyle, etc.) were lacking, thus
limiting statistical signiﬁcance (Burton et al., 2009). P3G began to address
the harmonization of questionnaires (Fortier et al., 2010), the issues sur-
rounding population data and access (Fortin et al., 2011), as well as the
need for templates that could be used to prospectively ensure the future
interoperability of large biobanks (Wallace et al., 2009).pen access article under the CC BY-NThrough the years, P3G's mission has been to lead, catalyse, and co-
ordinate international efforts and expertise relating to policy and data
harmonization for studies, biobanks, research databases and other
health and social research infrastructures, in order to improve the
health of individuals and populations. P3G's tools, support and network
help the international research community to use health and social data
for health care strategies aimed at disease prevention and tailored treat-
ments. Finally, P3G is committed to:
• maintaining a global vision of the scientiﬁc, technical, ethical, legal,
social environmental, economic and behavioural issues;
• promoting pre-competitive data sharingwhilst respecting all applica-
ble legal and ethical obligations; and
• supporting and enabling wide access to research tools and expertise.
P3G comprises over 450 individual and institutionalmembers. It was
founded on a common shared philosophy of data harmonization and
sharing under a common ethical framework, as expressed in a Charter
of Principles:- Mutual respect: The development and sustainability of P3G is based on responsi-
bility, collaboration, co-operation, trust and mutual respect for others, which
C-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
includes recognition of cultural diversity and the scientiﬁc speciﬁcity of the pro-
jects involved.
- Accountability: All standards, processes and procedures will be transparent and
clear, developed on the basis of consensus, and aim to create best practice in
the networking of population genomics resources.
- Proportionality: All research materials (such as data and samples) must be
protected to the highest standards of privacy and propriety, whilst at the same
time allowing and promoting the free exchange of ideas, datasharing and open-
ness for the beneﬁt of all.
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teroperability of large population cohorts by providing expertise and
fostering interoperability. Now in Phase II (2013–), the focus of P3G is
on access and use of genomic research and clinical databases, so as to
move towards genomic medicine and address the issues that arise
during this translation.
2. P3G Phase I (2004–2012)— fostering interoperability of large
population cohorts
At the outset, P3G createdﬁve InternationalWorkingGroups (IWGs)
on:
1) socio-demographic health;
2) physical/physiological/biochemical measurements;
3) storage, logistics and security;
4) governance and ethical clearance; and
5) public engagement.
The IWGs focused on the similarities and differences amongst
projects; key areas of collaboration; emerging issues; next steps; and
harmonization. In order to keep the community informed of their prog-
ress, the results of the IWG's ﬁndings were discussed and presented to
the membership at regular meetings.
One of P3G's ﬁrstmajor achievements was the creation of the Obser-
vatory. The P3G Observatory was launched at ameeting in Salt Lake City
in October 2005. Its main objectives were to provide support tools for
researchers in the harmonization, development, and implementation
of epidemiological and genomic studies; to disseminate scientiﬁc and
technical information developed and collected by P3G Cores and
IWGs; and to make feasible the comparison and sharing of information
and data between studies. The P3G Observatory quickly became a valu-
able tool amongst the biobanking community; not only did it contain in-
formation from worldwide, large population-based biobanks (N10,000
participants) (such that the number of cohorts listed soon amounted
to over 160), but also the information gathered was also made readily
available as cohorts emerged. This effectively ensured a large degree
of prospective harmonization and interoperability.
The P3G Catalogues in the Observatory comprised a wide range of
study descriptions, and many of them also linked to questionnaires,
physical/cognitive measurements, DNA analysis, etc. The Catalogues
provided access to both standard and detailed information on popula-
tion projects in genomics; facilitated the selection of projects by speciﬁc
criteria (study design, number of cases, etc.), and expedited the genera-
tion of synthesis tables.
Through compiling such information, disparities between cohorts,
the accumulated data, and different variables became readily apparent.
In response, P3G sought to harmonize such variables by developing
tools that would ease the integration of data across biological studies
(Fortier et al., 2010). In point of fact, one of these tools, DataSHaPER,
demonstrated that harmonization was possible (Fortier et al., 2011)
by retrospectively assessing 53 cohorts from 21 countries, which result-
ed in a harmonization rate of 62% of essential variables. This made pos-
sible the “virtual” aggregation of 6.9 million individuals on any of the
148 variables, thereby creating the necessary statistical signiﬁcance
(power).In short, the P3G Observatory provided the community with the re-
sources, tools and know-how to perfect data management and improve
methods of transfer and sharing. This result was consonant with P3G's
main objective — the creation of open, public and accessible datasets.
P3G's emphasis on transparency and collaboration not only enabled its
members (and any other entity that abided by its policies, and used its
tools) to enjoy horizontal access to data, but also legitimized the
works of P3G.
P3G became a much sought-after resource for establishing ground
rules and policies for the worldwide biobanking community. For in-
stance, several tools were developed by P3G and its partners to facilitate
the development of population research projects, including model
frameworks for the governance of biobanks, generic models of consent
forms or information pamphlets, and core elements and clauses for sam-
ples and data access agreements (www.p3g.org/resources/biobank-
toolkit, accessed 24 Sept. 2013).
These endeavours enabled P3G members to keep abreast of new
development, and to respond to community-based needs. P3G subse-
quently engaged in the conceptualization andpublication of statements.
For example, P3G prepared the principles for the elaboration of a data
sharing code of conduct (Knoppers et al., 2011), and a policy statement
framing the return of research results and incidental ﬁndings particular
to population studies (Knoppers et al., 2012).
On the international scene, P3G quickly established itself as a major
player, able to address issues and needs. For instance, P3G proposed a
roadmap for biobanks to enhance data pooling, so as to ease and accel-
erate international collaborations (Harris et al., 2012).
3. Phase II (2013–) — promoting access and use of research and
clinical databases
P3G developed as a ﬂuid and ﬂexible organisation, able to modify its
trajectory and adapt according to the needs of its community. In order
to better serve the research community, P3G prepared Phase II in
2012. As P3G had already built a foundation for biobanks, it soon
began to address the needs arising from the usage of and access to
biobanks. This shift necessitated major changes in the focus, mission
and structure of P3G. Thus, P3G changed its name to Public Population
Project in Genomics and Society to better reﬂect the societal aims of
the consortium, and its optimization of access to and use of population
studies. P3G also broadened its mission to include social science data-
bases and linkage with administrative and personal health records
and databases, for incorporation into societal health systems the crea-
tion of diverse research programmes with distinct platforms and a
new suite of tools.
3.1. Mission
In early 2012, P3G began to prepare Phase II, having achieved the
critical mass needed to become the principal international body for
the harmonization of public population studies in genomics and society.
Structural changes and new tools were needed tomeet the challenge of
optimising the use of and access to biobanks and cohort studies, togeth-
er with a new emphasis on integrating social science, administration,
and clinical data.
3.2. Structure
P3G remains governed by its Assembly of Members, and operates
pursuant to its Board of Directors as a non-proﬁt international consor-
tium. The Board is itself composed of a Finance Sub-Committee and a
Member's Sub-Committee. Scientiﬁc guidance is provided by an Inter-
national Steering Committee (ISC), and the P3G's secretariat works in
collaboration with three research programmes to promote the realisa-
tion of research endeavours for the beneﬁt of the entire research com-
munity (www.p3g.org/about-p3g/glance — accessed 24 Sept. 2013).
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with many research groups that have beneﬁted from the organisation's
expertise, networks and support. In particular, in its early years, various
IWCs sought to identify and keep track of trends and issues in the
biobanking community. In this new phase, P3G fostered the develop-
ment and activity of afﬁliated programmes to replace the IWCs by
re-centering its support for these programmes. At present, three such
research programmes are ofﬁcially afﬁliatedwith P3G: the Centre of Ge-
nomics and Policy Programme; the Maelstrom Research Programme;
and the P3G International Paediatric Research Platform.
The Centre of Genomics and Policy Programme (Director: Bartha M.
Knoppers) includes an international policy database (www.humgen.
com) and researchplatforms that provide ELSI toolkits and policy advice
for projects, as well as templates for researchers and for ethics and ac-
cess review committees. Currently, the CGP's research covers ﬁve
areas of genomics and policy: procreation and reproductive genetics,
paediatric health, privacy, public health, and, personalized medicine.
The Maelstrom Research Programme (Directors: Drs Isabel Fortier
and Vincent Ferretti) is an epi-IT research programme that seeks to
optimise the use of study data and to facilitate collaboration amongst
networks or study consortia. The Maelstrom Research Programme pro-
vides the research community with methods, open-source software,
and expert advice to support valid data comparison and harmonization
across studies.
The P3G International Paediatric Research Programme (Director: Ellen
Wright Clayton) builds a common approach to the tools and resources for
the facilitation, harmonization andmanagement of ELSI issues in interna-
tional paediatric research biobanking through the international expertise
of itsmembers. Its ﬁrst policy statement centred on the issue ofwhole ge-
nome sequencing and the return of incidental ﬁndings of medical signiﬁ-
cance considered to be in the best interests of the child (Knoppers et al.,
2013a, 2013b). Similar efforts also resulted in a generic access agreement
to ensure uniformity of legal and ethical access, in terms of both data and
materials (Knoppers et al., 2013a, 2013b).
3.3. Services to the research community
P3G supports activities relating to meeting, events and knowledge
development and transfer by promoting innovation, valorisation, and
the implementation of knowledge.
3.3.1. Support for innovation — P3G meetings and events
P3G regularly organises and co-organises meetings and networking
opportunities for its members. Whether stand-alone or part of a larger
event, these events are always speciﬁcally tailored to speciﬁc issues,
and allow for a constant re-alignment of priorities. P3G is committed
to ﬁnding solutions that beneﬁt itsmany partnerships. As a result, it fos-
ters and supports collaborations with its institutional members.
For instance, following a workshop co-organised by P3G at the
Brocher Foundation in Geneva, Switzerland (2011), it became clear
that ELSI research in genomics had achieved global expansion over the
last 20 years, and had promoted scholarship on the implications of ge-
nomic information for communities, societies, and cultures. Discussions
included consideration of the scholarly needs of those around theworld
who study genomic issues; strategies for improving communication
and collaboration across national research groups and centres; and,
approaches for engaging communities, policy-makers, and patient
groups in genomics and society research. The workshop concluded
that there was a need to stimulate creativity, communication and col-
laboration on genomic research and policy. This conclusion resulted in
the creation of the ELSI 2.0 Collaboratory (Kaye et al., 2012), an initiative
which focuses on fostering international collaboration in ELSI genomics,
in order for researchers to better assess the impact and dynamics of
global genome research. To accommodate the ELSI 2.0 Collaboratory,
P3G built an online workspace for all potential users that provided
opportunities to be involved in and to contribute to local, regional,and international policy and practice. In 2014, ELSI 2.0 became the
fourth P3G research programme.
3.3.2. Support for knowledge development — P3G HUBs
Another aspect of P3G services is the implementation of speciﬁc
modules or HUBs as the need arises amongst P3G partners. A network
of online agoras was created for close contact between researchers in-
terested in discussion, exchange and collaboration. An expanded search
function has been established on P3G's website, and HUBs are dedicated
and designed per the speciﬁcations of the groups that wish to use them
(www.p3g.org/resources/biobank-hub — accessed Sept. 24 2013). Re-
cent developments, news and publications are updated regularly. The
HUB can also include features such as discussion forums and portals
for the exchange of documents and other ﬁles. HUBs are emblematic
of P3G's ability to harness the expertise of its members, and thereby
encourage the development of the organisation in unique ways with
human-to-human connections. With its logistical aspects being man-
aged by P3G, any HUB can provide information on research resources
and prospective projects, and workspaces for online collaboration. A
HUB can also include educational webinars and workshops, and can
support strategic activities including reviews and meta-analyses of
ELSI research and policy; development of foresight papers; rapid
response action teams to advise on speciﬁc issues; international
memos for identifying emergingpolicy issues and priorities; andmodel-
ling exercises for the construction of international frameworks and
approaches.
In terms of knowledge development, P3G also hosts the Bioresource
Research Impact Factor (BRIF) pilot project (Cambon-Thomsen et al.,
2011). Currently set up as a pilot project within BioSHaRE.EU (Biobank
Standardisation and Harmonisation for Research Excellence (FP7
EuropeanUnion)), the BRIF initiative is developing a framework for cre-
ating a tool to provide a unique digital resource identiﬁer to calculate
the research impact of bioresources, and to trace citation and attribution
of bioresources in research. Each cohort/collection/database used in the
project can obtain a unique identiﬁer from P3G for their bioresource;
this identiﬁer will then be used to identify the bioresource in its
broadest form.
3.3.3. Support for knowledge valorisation and implementation — P3G
website and the IPAC
P3G also offers support for knowledge valorisation and implementa-
tion using two main sources: the P3G website and the IPAC.
3.3.3.1. The P3G website. Perhaps the most remarkable resource that P3G
offers is its website, which contains a wealth of information (www.p3g.
org— accessed 24 Sept. 2013). Thewebsite, which has been completely
revamped, is an easy-to-navigate compendium of tools and resources. It
was redesigned with a view to the needs of biobanks and other entities
involved in health and social research, and is especially suited to infra-
structures that work towards improving the health of individuals and
populations.
Thewebsite'smain frame is divided, using an easy-to-access toolbar,
into six sections, each pertaining to a different aspect of biobanking.
Each resource can be used by the international research community
and stakeholders, such as biobank managers, bioethicists, research/cli-
nician teams, funders, lawyers, policymakers, groups seeking assistance
in the development of biobank infrastructures, and any other party as
they see ﬁt. In addition to the HUB and the BRIF as described above,
the website also offers the TOOLKIT, the LIFESPAN, the CATALOGUES
and the TRAINING modules.
i) TOOLKIT
The TOOLKIT is a one-stop shop for epidemiological, ethical, sta-
tistical and IT tools for the access and use of biobanks (www.p3g.
org/resources/biobank-toolkit — accessed 24 Sept. 2013). These
tools include relevant websites, documents and software.
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also allowed to add their own tools to those already present
and either customize the tools themselves, or ask P3G to custom-
ize them.
The TOOLKIT was built from resources gleaned and/or created
by P3G, and aims to provide useful tools relating to studies,
biobanks, research databases and other similar health and so-
cial research infrastructure. These tools are relevant at every
stage of the biobank lifecycle — i.e., conception, building, use
or closure of a biobank. Tools that are distantly related to
biobanking are also included if they address speciﬁc needs of
the community.
As with any other work-in-progress, members can suggest
and propose new tools for inclusion to the P3G International
Steering Committee. To be considered suitable for the P3G
web platform, tools must satisfy the following four criteria:
• they must be relevant to studies, biobanks, research databases
and other similar health and social research infrastructure
aimed at improving the health of individuals and populations;
• they must be useful across different projects (i.e. tools must be
standardised and useful to a large number of users);
• any website/document/software must have been recently up-
dated; and
• they must be open access.
For ease of use, the TOOLKITmodule of the P3Gwebsite consists
of a searchable platform through which users can not only
search by speciﬁc tool name, but also select tools using differ-
ent criteria in order to seek crucial, to-the-point information.
These criteria include choice by category (i.e. epidemiology
and biostatistics, sample collection and processing, data collec-
tion and processing, ELSI, etc.), and/or type of tool (i.e. docu-
ments vs. software vs. websites). The user also has the option
of narrowing his or her search, thereby limiting results to
P3G-developed tools.
The TOOLKIT was designed to simplify the search for relevant
tools for the biobank community. As P3G continues to test
and survey the needs of website users, several components of
the TOOLKIT will become increasingly interactive.
ii) LIFESPAN
The biobank LIFESPAN module provides an open access web
module offering users a step-by-step approach to the develop-
ment and maintenance of biobanks; this module is a complete
map of the biobank lifecycle, from building and maintenance, to
use and closure. Appropriate tools were identiﬁed and mapped
onto the biobank lifecycle (www.p3g.org/resources/biobank-
lifespan — accessed Sept. 24 2013).
Tools are assigned in chronological order of use, considering the
four different phases of the biobank lifecycle:
1 — conceptualization and design of biobanks: this ﬁrst phase in-
cludes planning, design and creation, and provides governance
tools, funding mechanisms, ethics tools, and public engage-
ment tools;
2 — construction of biobanks: this phase is the most intensive in a
biobank's lifespan, as it consists of set-up and operations
(data collection and handling, questionnaires, physical and
cognitive measures, software and IT tools, consent tools, and
privacy tools);
3 — biobank usage: this third phase is the essence of biobanking it
concerns how data is used and accessed (data analysis tools,
harmonization tools, biostatistics tools, data access policies
and procedures, intellectual property management, return of
results tools, and public communication of research); and
4 — biobank closure: this phase is the decommissioning phase,
which occurs once the resource has reached its conclusion
(seeking approvals and other such implications).At each of these phases, users are offered a variety of ‘Steps’
that link to relevant tools (documents, software and/or
websites) to better orient their activities, as well as a chart of
‘Tasks and Needs’, that was developed by P3G experts.
iii) CATALOGUES
The P3G Partner CATALOGUES provide easy access to information
about large population-based biobanks (www.p3g.org/resources/
biobank-catalogues — accessed 24 Sept. 2013). They describe,
index and present information about various technical aspects of
studies; their aim is to support the development and harmoniza-
tion of epidemiological projects in genomics by providing an
overview of a range of biobanking aspects.
The P3G Catalogues contain information obtained by P3G during
data collection, via websites and other open access resources, or
compiled following close interaction with the partner team that
set up each of the given research studies. The study description
is constantly updated as the research project develops, with infor-
mation supplied by relevant resources. In addition to a study
description, complementary elements are often also made avail-
able, such as:
1 — Questionnaire Catalogue, including reference questionnaires
from large population-based studies; these aim to facilitate
the development and harmonization of questionnaires. The
catalogue gives access to questionnaires administered at the
recruitment of the participant; their methods of administra-
tion; and an overview of the similarities and differences of
the information;
2 — Physical and Cognitive Measures Catalogue, providing an
overview of the physical and cognitive measures;
3 — DNA Processing Catalogue, offering an overview from sample
storage to DNA quality control including DNA storage and
extraction; and
4 — Access Catalogue, which provides an overview of information
relating to access of study data and samples.
The Catalogues have proven very useful to many stakeholders
in the research community; the wide-ranging database of re-
sources can provide highly valued information to be applied
to a variety of different projects. This suite of catalogues is at
the core of the P3G mission, as it constitutes a solid scientiﬁc
foundation on which the members and partners can rely.
iv) TRAINING
The TRAINING module links users to tutorials and information
sessions on how to use the P3G website, as well as speciﬁc tools
(www.p3g.org/resources/biobank-training — accessed 24 Sept.
2013).
With a view to complementing and enhancing the TOOLKIT and
the LIFESPAN modules, the TRAINING module accompanies the
user in the learning process via contact with experts. This can
take many different forms, such as web tutorials/webcasts or ex-
pert mentoring.
3.3.3.2. Promoting access and use: the International Policy interoperability
and data Access Clearinghouse (IPAC). In order to complement P3G's
Phase II objectives, in particular the facilitation of access to and effective
utilization of the data and samples that exist in large cohorts, P3G has
developed new services to meet the changing needs of the research
community.
The International Policy interoperability and data Access Clearing-
house (IPAC) (www.p3g.org/ipac— accessed Sept. 24 2013) is a collab-
oration between P3G and the Centre of Genomics and Policy (CGP) at
McGill University, whereby expertise services for ELSI screening and
data access compliancewill be offered to researchers/consortia/industry
and biobanks. The goal is to provide a “one stop” screening service for
policy interoperability and access authorization so as to support, co-
ordinate, and, facilitate access and use of research data. One of the ﬁrst
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ment prepared by P3G's International Scientiﬁc Committee. It seeks to
ensure uniformity of legal and ethical access, in terms of both data and
materials.
Both policy interoperability and access authorization to data require
the development of policies and procedures and the examination of
conformity of requests with national laws. Also, narrow consent and
the failure to notify research participants of possible or eventual com-
mercialization and international datasharing can block actual and future
collaboration. Legacy collections that seemingly fail to meet modern
ethics requirements are not used. The creation of the IPAC will be the
ﬁrst step to fostering and facilitating data sharing via international in-
teroperability mechanisms. It would also raise levels of assurance and
accountability. As an independent, third-party access brokerwith requi-
site expertise, credibility and international legitimacy, IPACwill provide
an “ethical safe harbour” environment by authorizing requests for ac-
cess in accordance with harmonized principles and tools. The added
value of IPAC's intervention as both a policy interoperability tool provid-
er and an intermediary data access broker would be to alleviate resis-
tance to data sharing, promote interoperability, and facilitate
preparation for successful ethics/privacy/access review, thereby reduc-
ing unnecessary bureaucracy and delays. IPAC proposes a range of ser-
vices in four languages (English, French, Spanish and Arabic):
1 — policy interoperability services such as international comparative
analysis of consents (legacy collections); preparation of policies
and consents for de novo projects or preparation of templates for
customized access agreements; and preparation of international
codes of conduct, policies and procedures, ongoing monitoring
and governance mechanisms;
2 — access services that include the review of data and samples access
request/authorization and compliance e.g. creation of a project-
personalized Data Access Compliance Ofﬁce (“DACO”); reception
and review of applications for access to controlled datasets, in con-
formity with the goals and policies of the project; development or
assessment for prospective and retrospective harmonization; and
serving as the depository, ensuring the conﬁdentiality of paper
copies of applications/conﬁdentiality agreements and other DACO
material of sensitive nature.
4. Conclusion
As its mission and range of activities expand, P3G will continue
to keep abreast of developments in the global world of biobanking
and related aspects to evolve and redeﬁne itself. As P3G embarks on col-
laborations with a wider range of projects, including the nascent Global
Alliance for Genomics and Health (http://www.humanvariomeproject.org/index.php/news/237-a-global-alliance-to-enable-responsible-
sharing-of-genomic-and-clinical-data — accessed 17 November 2013),
the consortium and its secretariat continue to be an enabler and provid-
er of services at the very heart of international genetic research. P3Gwill
endeavour to lead, catalyse, and coordinate international efforts and ex-
pertise to optimise the use of studies, biobanks, research databases and
other similar health and social research infrastructure with a view to
improving the health of individuals and populations and easing the
translation to clinical research.
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